Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma - Poll - MDSpire

Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma

  • By

  • Amit Kumar Mitra

  • Ujjal Kumar Mukherjee

  • Suman Mazumder

  • Vithal Madhira

  • Timothy Bergquist

  • Yu Raymond Shao

  • Feifan Liu

  • Qianqian Song

  • Jing Su

  • Shaji Kumar

  • Benjamin A. Bates

  • Noha Sharafeldin

  • Umit Topaloglu

  • December 7, 2023

  • 0 min

Share

Original Source(s)

Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma

  • by Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, Feifan Liu, Qianqian Song, Jing Su, Shaji Kumar, Benjamin A. Bates, Noha Sharafeldin, Umit Topaloglu

  • December 7, 2023

Related Content

Case Study: Non-secretory Multiple Myeloma with Eosinophilia - Diagnostic Hurdles and a Comprehensive Literature Review

Prognostic Impact of Early Disease Progression and Early Mortality in Patients with Multiple Myeloma: A Real-World Cohort Study

Differential expression of immune activation markers in T cells from patients with multiple myeloma